The effects of two endogenous mammalian
FMRFamide (Phe-Met-Arg-Phe-NH2)-related
peptides, an
octapeptide F8Fa (Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2) and an octadecapeptide
A18Fa (Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Pro-Gln-Arg-Phe-NH2 ), and
IgG from serum against them on the responses to aggression and defeat-induced
analgesia were examined in subordinate mice in "resident-intruder" pairings. Intracerebroventricular (ICV) administrations of F8Fa and
A18Fa (0.10-10 micrograms) reduced, in a dose-dependent manner, the number of
bites to obtain defeat in the subordinate mice during the agonistic encounters, as well as attenuating defeat-induced
analgesia, with F8Fa having a greater inhibitory effect than
A18Fa. Peripheral administration of
naloxone (1.0 mg/kg) had a similar inhibitory effect on the number of
bites to defeat and the level of defeat-induced
analgesia. In contrast, ICV administrations of F8Fa-IgG and A18Fa-IgG
antisera increased the number of
bites to defeat and augmented the levels of defeat-induced
analgesia, with F8Fa-IgG having a greater effect than A18Fa-IgG. These results provide further evidence that the
peptides, F8Fa and
A18Fa, are involved in the modulation of
opioid-mediated
analgesia accompanying
biological stressors and suggest that these endogenous FMRF-NH2-related
peptides may also be associated with the expression of
opioid-sensitive components of aggressive behavior.